3,4-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)benzoic acid, 97%, 5g

(S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid hydrochloride, 98%, 5g

(Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide, 95.0%, 100mg

2,6-Difluoro-4-methylaniline, 95.0%, 1g

4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide hydrochloride, 95%, 5g

2-((4-Methyl-2-nitrophenyl)amino)ethanol, 95.0%, 5g

4-Aminophenylarsonic Acid>98.0%(HPLC)(T)500g

N-Methyl-N'-cyclohexyl ethylenediamine, 98%, 5g

3,3'-Di(9H-carbazol-9-yl)-1,1'-biphenyl>98.0%(HPLC)(N)200mg

GC capillary column ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

tert-Butyl 4-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 250mg

(S)-tert-Butyl (1-hydroxypropan-2-yl)carbamate, 98.0%, 5g

N-[4-(Trifluoromethyl)benzyl]piperidin-4-amine dihydrochloride, 1g